The DOI matches its Crossref record; 67 of the 68 references it cites were found in a registry or an index.
An introduction to the free radical hypothesis in Parkinson's disease
Abstract
Iron-induced oxidant stress has been implicated in the pathogenesis of Parkinson's disease. An increasing body of evidence now indicates that in Parkinson's disease the environment within the substantia nigra is conducive to the formation of cytotoxic free radicals and cell degeneration. Dopamine neurons may be particularly vulnerable because of the oxidative metabolism of dopamine and the potential of neuromelanin to promote the site-specific accumulation and reduction of iron. This hypothesis has attracted considerable attention because it opens the way for employing antioxidant strategies as possible neuroprotective treatment for Parkinson's disease. Although the concept is appealing, free radicals have not yet been proven to play a role in Parkinson's disease, and many important issues remain to be resolved before the oxidative hypothesis can ultimately be confirmed or refuted.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“This observation is in agreement with a similar analysis that was performed on autopsy specimens ([51](#R51)).”
From Medial temporal atrophy on MRI in normal aging and very mild Alzheimer's disease (1997) · cites this paper as [51]
Citations
Cites
McCord, J. M., & Fridovich, I. (1969) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)63504-5 · Cited by 12,952
Oxygen toxicity, oxygen radicals, transition metals and disease
Halliwell, B., & Gutteridge, J. M. C. (1984) · Biochemical Journal · doi:10.1042/bj2190001 · Cited by 5,330
Mitochondrial DNA and human evolution
Cann, R. L., Stoneking, M., & Wilson, A. C. (1987) · Nature · doi:10.1038/325031a0 · Cited by 3,100
Oxygen free radicals and iron in relation to biology and medicine: Some problems and concepts
Halliwell, B., & Gutteridge, J. M. C. (1986) · Archives of Biochemistry and Biophysics · doi:10.1016/0003-9861(86)90305-x · Cited by 2,038
DNA damage and oxygen radical toxicity
Imlay, J. A., & Linn, S. (1988) · Science · doi:10.1126/science.3287616 · Cited by 1,974
Oxygen radicals and human disease
CROSS, C. E., HALLIWELL, B., BORISH, E. T., PRYOR, W. A., AMES, B. N., SAUL, R. L., McCORD, J. M., & HARMAN, D. (1987) · Annals of Internal Medicine · doi:10.7326/0003-4819-107-4-526 · Cited by 1,856
MITOCHONDRIAL COMPLEX I DEFICIENCY IN PARKINSON'S DISEASE
Schapira, A. H. V., Cooper, J. A. D., Dexter, D. T., Jenner, P. G., Clark, J. B., & MARSDEN, C. D. (1989) · The Lancet · doi:10.1016/s0140-6736(89)92366-0 · Cited by 1,757
The effect of age on the non-haemin iron in the human brain
Hallgren, B., & Sourander, P. (1958) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1958.tb12607.x · Cited by 1,427
Basal Lipid Peroxidation in Substantia Nigra Is Increased in Parkinson's Disease
Dexter, D. T., Carter, C. J., Wells, F. R., Javoy-Agid, F., Agid, Y., Lees, A. J., Jenner, P. G., & MARSDEN, C. D. (1989) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1989.tb09133.x · Cited by 1,397
Transition metals, ferritin, glutathione, and ascorbic acid in parkinsonian brains
Riederer, P., Sofic, E., Rausch, W., Schmidt, B., Reynolds, G. P., Jellinger, K., & Youdim, M. B. H. (1989) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1989.tb09150.x · Cited by 1,383
Research works printed but not linked: 14
- Halliwell, 1985, TINS, 8, 22
- Cohen, 1990, Neural Transm, 32, 229
- Olanow, 1990, Neurology, 40, 32
- Halliwell, 1988, ISI Atlas Sci Biochem, 1, 48
- Potts, 1976, Exp Eye Res, 48, 221
- Sarna, 1976, Science, 1132, 192
- Brain iron: MRI studies in Parkinson's syndrome. In: eds. Florham Park, New Jersey: MacMillan Healthcare, 1987: 135-143
- Sengstock, 1991, Movement Dis, 6, 272
- Olanow, 1991, Neurology, 42, 13
- Riederer, 1989, J Neurochem, 52, 515, 10.1111/j.1471-4159.1989.tb09150.x · DOI · Paper page
- Good, 1992, J Neuropathol Exp Neurol, 51, 327
- et al. Vitamin E levels in brain are not altered in Parkinson's disease. Ann Neurol 1992 (in press)
- et al. Brain skeletal muscle and platelet mitochondrial function in Parkinson's disease. Brain 1992 (in press)
- Spina, 1988, J Pharmacol Exp Ther, 247, 502
Cited by
Sorted by citations
Rosen, D. R., Siddique, T., Patterson, D., Figlewicz, D. A., Sapp, P., Hentati, A., Donaldson, D., Goto, J., O'Regan, J. P., Deng, H.-X., et al. (1993) · Nature · doi:10.1038/362059a0 · Cited by 7,062
Wang, H., & Joseph, J. A. (1999) · Free Radical Biology and Medicine · doi:10.1016/s0891-5849(99)00107-0 · Cited by 2,355
Hydrogen peroxide mediates amyloid β protein toxicity
Behl, C. (1994) · Cell · doi:10.1016/0092-8674(94)90131-7 · Cited by 2,074
Braak, H., R�b, U., Gai, W. P., & Del Tredici, K. (2003) · Journal of Neural Transmission · doi:10.1007/s00702-002-0808-2 · Cited by 1,683
Medial temporal atrophy on MRI in normal aging and very mild Alzheimer's disease
Jack, C. R., Petersen, R. C., Xu, Y. C., Waring, S. C., O'Brien, P. C., Tangalos, E. G., Smith, G. E., Ivnik, R. J., & Kokmen, E. (1997) · Neurology · doi:10.1212/wnl.49.3.786 · Cited by 1,128
Joseph, J. A., Shukitt-Hale, B., Denisova, N. A., Bielinski, D., Martin, A., McEwen, J. J., & Bickford, P. C. (1999) · The Journal of Neuroscience · doi:10.1523/jneurosci.19-18-08114.1999 · Cited by 980
Nanoparticles in cellular drug delivery
Faraji, A. H., & Wipf, P. (2009) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2009.02.043 · Cited by 937
A radical hypothesis for neurodegeneration
Olanow, C. W. (1993) · Trends in Neurosciences · doi:10.1016/0166-2236(93)90070-3 · Cited by 722
Self-citationBains, J. S., & Shaw, C. A. (1997) · Brain Research Reviews · doi:10.1016/s0165-0173(97)00045-3 · Cited by 718
Immunocytochemical analysis of tumor necrosis factor and its receptors in Parkinson's disease
Boka, G., Anglade, P., Wallach, D., Javoy-Agid, F., Agid, Y., & Hirsch, É. C. (1994) · Neuroscience Letters · doi:10.1016/0304-3940(94)90684-x · Cited by 600
Reactive oxygen species (ROS) play an important role in a rat model of neuropathic pain
Kim, H., Park, S., Zhou, J.-L., Taglialatela, G., Chung, K., Coggeshall, R., & Chung, J.-M. (2004) · Pain · doi:10.1016/j.pain.2004.06.008 · Cited by 451
Cardiac Sympathetic Denervation in Parkinson Disease
Goldstein, D. S., Holmes, C., Li, S.-T., Bruce, S., Metman, L. V., & Cannon, R. O. (2000) · Annals of Internal Medicine · doi:10.7326/0003-4819-133-5-200009050-00009 · Cited by 372
Joseph, J. A., Shukitt‐Hale, B., & Casadesús, G. (2005) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/81.1.313s · Cited by 368
The effect of deprenyl and levodopa on the progression of Parkinson's disease
Olanow, C. W., Hauser, R. A., Gauguster, L., Malapira, T., Koller, W. C., Hubble, J. P., Busenbark, K. L., Lilienfeld, D. E., & Esterlitz, J. (1995) · Annals of Neurology · doi:10.1002/ana.410380512 · Cited by 334
Self-citationImproving the Survival of Grafted Dopaminergic Neurons: A Review over Current Approaches
Brundin, P., Karlsson, J., Emgård, M., Schierle, G. S. K., Hansson, O., Petersén, Å., & Castilho, R. F. (2000) · Cell Transplantation · doi:10.1177/096368970000900205 · Cited by 333
McWhir, J., Selfridge, J., Harrison, D. J., Squires, S., & Melton, D. W. (1993) · Nature Genetics · doi:10.1038/ng1193-217 · Cited by 323
Pandi-Perumal, S. R., BaHammam, A. S., Brown, G. M., Spence, D. W., Bharti, V. K., Kaur, C., Hardeland, R., & Cardinali, D. P. (2012) · Neurotoxicity Research · doi:10.1007/s12640-012-9337-4 · Cited by 320
Role of metal dyshomeostasis in Alzheimer's disease
Bonda, D., Lee, H., Blair, J. A., Zhu, X., Perry, G. L., & Smith, M. A. (2011) · Metallomics · doi:10.1039/c0mt00074d · Cited by 316
Iron and mechanisms of emotional behavior
Kim, J., & Wessling‐Resnick, M. (2014) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2014.07.003 · Cited by 314
Qin, L., Liu, Y., Cooper, C. L., Liu, B., Wilson, B. C., & Hong, J. (2002) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2002.01210.x · Cited by 294
Are mitochondria critical in the pathogenesis of Alzheimer's disease?
Reddy, P. H., & Beal, M. F. (2005) · Brain Research Reviews · doi:10.1016/j.brainresrev.2005.03.004 · Cited by 294
The Effects of Methamphetamine on the Production of Free Radicals and Oxidative Stress
Yamamoto, B. K., & Zhu, W. (1998) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)37769-9 · Cited by 281
A detailed analysis of hydrogen peroxide-induced cell death in primary neuronal culture
Whittemore, E. R., Loo, D. T., Watt, J. A., & Cotmans, C. W. (1995) · Neuroscience · doi:10.1016/0306-4522(95)00108-u · Cited by 268
Gao, X. M., Kim, H. K., Chung, J. M., & Chung, K. (2007) · Pain · doi:10.1016/j.pain.2007.01.011 · Cited by 253
Greenberg, S. M. (1998) · Neurology · doi:10.1212/wnl.51.3.690 · Cited by 244
Parkinson Disease, the Effect of Levodopa, and the ELLDOPA Trial
Fahn, S. (1999) · Archives of Neurology · doi:10.1001/archneur.56.5.529 · Cited by 254
The neuroprotective role of melatonin in neurological disorders
Alghamdi, B. S. A. (2018) · Journal of Neuroscience Research · doi:10.1002/jnr.24220 · Cited by 234
Oxidative Stress Associated with Neuronal Apoptosis in Experimental Models of Epilepsy
Armenta, M. M., Nava-Ruíz, C., Juárez-Rebollar, D., Rodrı́guez-Martı́nez, E., & Gómez, P. Y. (2014) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2014/293689 · Cited by 233
Tumor Necrosis Factor α Is Toxic to Embryonic Mesencephalic Dopamine Neurons
McGuire, S. O., Ling, Z. D., Lipton, J. W., Sortwell, C. E., Collier, T. J., & Carvey, P. M. (2001) · Experimental Neurology · doi:10.1006/exnr.2001.7688 · Cited by 222
Zhu, J., Mu, X., Zeng, J., Xu, C., Liu, J., Zhang, M., Li, C., Chen, J., Li, T.-Y., & Wang, Y. (2014) · PLoS ONE · doi:10.1371/journal.pone.0101291 · Cited by 223
Berry Fruit Supplementation and the Aging Brain
Shukitt‐Hale, B., Lau, F. C., & Joseph, J. A. (2008) · Journal of Agricultural and Food Chemistry · doi:10.1021/jf072505f · Cited by 218
Evidence for mitochondrial dysfunction in Parkinson's disease—a critical appraisal
Schapira, A. H. V. (1994) · Movement Disorders · doi:10.1002/mds.870090202 · Cited by 218
The beneficial effects of fruit polyphenols on brain aging
Lau, F. C., Shukitt-Hale, B., & Joseph, J. A. (2005) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2005.08.007 · Cited by 217
Goyarzu, P., Malin, D. H., Lau, F. C., Taglialatela, G., Moon, W. D., Jennings, R., Moy, E., Moy, D. M., Lippold, S., Shukitt‐Hale, B., et al. (2004) · Nutritional Neuroscience · doi:10.1080/10284150410001710410 · Cited by 213
van den Bent, M. J., Kros, J. M., Heimans, J. J., Pronk, L. C., van Groeningen, C. J., Krouwer, H. G. J., TAPHOORN, M. J. B., Zonnenberg, B. A., Tijssen, C. C., Twijnstra, A., et al. (1998) · Neurology · doi:10.1212/wnl.51.4.1140 · Cited by 206
Olanow, C. W., Fahn, S., Muenter, M. D., Klawans, H. L., Hurtig, H. I., Stern, M., Shoulson, I., Kurlan, R., Grimes, J. D., Jankovic, J. J., et al. (1994) · Movement Disorders · doi:10.1002/mds.870090107 · Cited by 204
Self-citationRisk of cancer from azathioprine therapy in multiple sclerosis
Confavreux, C., Saddier, P., Grimaud, J., Moreau, T., Adeleine, P., & Aimard, G. (1996) · Neurology · doi:10.1212/wnl.46.6.1607 · Cited by 203
Copernicus revisited: amyloid beta in Alzheimer's disease
Josepha, J. A. (2001) · Neurobiology of Aging · doi:10.1016/s0197-4580(00)00211-6 · Cited by 206
Grape Juice, Berries, and Walnuts Affect Brain Aging and Behavior
Joseph, J. A., Shukitt‐Hale, B., & Willis, L. (2009) · Journal of Nutrition · doi:10.3945/jn.109.108266 · Cited by 203
Curcumin reduces α-synuclein induced cytotoxicity in Parkinson's disease cell model
Wang, M. S., Boddapati, S. P., Emadi, S., & Sierks, M. R. (2010) · BMC Neuroscience · doi:10.1186/1471-2202-11-57 · Cited by 200
Aluminium and the risk for alzheimer's disease
McLachlan, D. R. C. (1995) · Environmetrics · doi:10.1002/env.3170060303 · Cited by 196
Reactive oxygen/nitrogen species and their functional correlations in neurodegenerative diseases
Ramalingam, M., & Kim, S. (2012) · Journal of Neural Transmission · doi:10.1007/s00702-011-0758-7 · Cited by 194
Sawada, H., Ibi, M., Kihara, T., Urushitani, M., Akaike, A., Kimura, J., & Shimohama, S. (1998) · Annals of Neurology · doi:10.1002/ana.410440117 · Cited by 193
Brain Iron Metabolism Dysfunction in Parkinson’s Disease
Jiang, H. F., Wang, J., Rogers, J. T., & Xie, J. (2016) · Molecular Neurobiology · doi:10.1007/s12035-016-9879-1 · Cited by 188
Poor and protracted myelination as a contributory factor to neurodegenerative disorders
Braak, H., & Tredici, K. D. (2003) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2003.04.001 · Cited by 179
Sharma, N., & Nehru, B. (2017) · Inflammopharmacology · doi:10.1007/s10787-017-0402-8 · Cited by 181
Oxidative stress and apoptosis in neurodegeneration
Gorman, A. M., McGowan, A. J., O’Neill, C., & Cotter, T. G. (1996) · Journal of the Neurological Sciences · doi:10.1016/0022-510x(96)00097-4 · Cited by 173
Mitochondrial dysfunction in glaucoma and emerging bioenergetic therapies
Lee, S., Bergen, N. J. V., Kong, G. Y. X., Chrysostomou, V., Waugh, H. S., O’Neill, E. C., Crowston, J. G., & Trounce, I. A. (2010) · Experimental Eye Research · doi:10.1016/j.exer.2010.07.015 · Cited by 170
Yamamoto, B. K., & Raudensky, J. (2008) · Journal of Neuroimmune Pharmacology · doi:10.1007/s11481-008-9121-7 · Cited by 167
Nanoparticle and other metal chelation therapeutics in Alzheimer disease
Liu, G., Garrett, M. R., Men, P., Zhu, X., Perry, G. L., & Smith, M. A. (2005) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2005.06.006 · Cited by 160
Miller, J. W., Selhub, J., & Joseph, J. A. (1996) · Free Radical Biology and Medicine · doi:10.1016/0891-5849(96)00033-0 · Cited by 157
Oestreicher, E., Sengstock, G. J., Riederer, P., Olanow, C. W., Dunn, A. J., & Arendash, G. W. (1994) · Brain Research · doi:10.1016/0006-8993(94)90833-8 · Cited by 156
Oxidative Stress and Parkinson's Diseasea
Owen, A., Schapira, A. H. V., Jenner, P. G., & MARSDEN, C. D. (1996) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1996.tb39064.x · Cited by 154
Reddy, P. H. (2006) · BioMed Research International · doi:10.1155/jbb/2006/31372 · Cited by 154
Schildknecht, S., Gerding, H. R., Karreman, C., Drescher, M., Lashuel, H. A., Outeiro, T. F., Di Monte, D. A., & Leist, M. (2013) · Journal of Neurochemistry · doi:10.1111/jnc.12226 · Cited by 148
Post, A., Holsboer, F., & Behl, C. (1998) · Journal of Neuroscience · doi:10.1523/jneurosci.18-20-08236.1998 · Cited by 146
Oxidative Stress and Inflammation in Brain Aging: Nutritional Considerations
Joseph, J. A., Shukitt‐Hale, B., Casadesús, G., & Fisher, D. (2005) · Neurochemical Research · doi:10.1007/s11064-005-6967-4 · Cited by 137
Temlett, J. A., Landsberg, J. P., Watt, F., & Orime, G. W. (1994) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1994.62010134.x · Cited by 137
Excitotoxicity, Oxidative Stress, and the Neuroprotective Potential of Melatonin
Skaper, S. D., Floreani, M., Ceccon, M., Facci, L., & Giusti, P. (1999) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1999.tb07985.x · Cited by 135
Saravanan, K. S., Madathil, S. K., & Mohanakumar, K. P. (2005) · Brain Research · doi:10.1016/j.brainres.2005.04.051 · Cited by 134
Duara, R., Barker, W., Lopez-Alberola, R., Loewenstein, D., Grau, L. B., Gilchrist, D. M., Sevush, S., & George‐Hyslop, P. S. (1996) · Neurology · doi:10.1212/wnl.46.6.1575 · Cited by 134
Kim, J., Lee, S., Shim, J., Kim, H. W., Kim, J., Jang, Y. J., Yang, H. S., Park, J., Choi, S. H., Yoon, J. H., et al. (2012) · Neurochemistry International · doi:10.1016/j.neuint.2012.02.004 · Cited by 133
Metabolic and Molecular Bases of Menkes Disease and Occipital Horn Syndrome
Kaler, S. G. (1998) · Pediatric and Developmental Pathology · doi:10.1007/s100249900011 · Cited by 131
Diagnosis and therapy of Menkes syndrome, a genetic form of copper deficiency
Kaler, S. (1998) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/67.5.1029s · Cited by 129
Zutter, G. S. D., & Davis, R. J. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.111027698 · Cited by 128
Clinical–Pathological study of levodopa complications
Rajput, A. H., Fenton, M. E., Birdi, S., Macaulay, R. J. B., George, D. H., Rozdilsky, B., Ang, L. C., Senthilselvan, A., & Hornykiewicz, O. (2002) · Movement Disorders · doi:10.1002/mds.10031 · Cited by 126
Analgesic effect of vitamin E is mediated by reducing central sensitization in neuropathic pain
Kim, H. K., Kim, J. H., Gao, X. M., Zhou, J.-L., Lee, I., Chung, K., & Chung, J. M. (2006) · Pain · doi:10.1016/j.pain.2006.01.013 · Cited by 128
Sloan, M. A., Price, T. R., Petito, C. K., Randall, A. M. Y., Solomon, R. E., Terrin, M. L., Gore, J. M., Collen, D., Kleiman, N. S., Feit, F., et al. (1995) · Neurology · doi:10.1212/wnl.45.4.649 · Cited by 122
Elemental imbalances in the olfactory pathway in Alzheimer's disease
Samudralwar, D. L., Diprete, C. C., Ni, B. F., Ehmann, W. D., & Markesbery, W. R. (1995) · Journal of the Neurological Sciences · doi:10.1016/0022-510x(95)00018-w · Cited by 116
Enochs, W. S., Sarna, T., Zecca, L., Riley, P. A., & Swartz, H. M. (1994) · Journal of Neural Transmission - Parkinsons Disease and Dementia Section · doi:10.1007/bf02260963 · Cited by 116
Botulinum toxin treatment of essential head tremor
Pahwa, R., Busenbark, K., Swanson-Hyland, E. F., Dubinsky, R. M., Hubble, J. P., Gray, C., & Koller, W. C. (1995) · Neurology · doi:10.1212/wnl.45.4.822 · Cited by 114
Yeo, J. E., & Kang, S. K. (2007) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2007.09.004 · Cited by 115
Srinivasan, V., Cardinali, D. P., Srinivasan, U. S., Kaur, C., Brown, G. M., Spence, D. W., Hardeland, R., & Pandi-Perumal, S. R. (2011) · Therapeutic Advances in Neurological Disorders · doi:10.1177/1756285611406166 · Cited by 116
Fruit Polyphenols and Their Effects on Neuronal Signaling and Behavior in Senescence
Joseph, J. A., Shukitt‐Hale, B., & Lau, F. C. (2007) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1395.052 · Cited by 114
Kaler, S. G. (1994) · Advances in Pediatrics · doi:10.1016/s0065-3101(24)00096-3 · Cited by 114
Blueberry supplemented diet reverses age-related decline in hippocampal HSP70 neuroprotection
Galli, R. L., Bielinski, D. F., Szprengiel, A., Shukitt‐Hale, B., & JOSEPH, J. (2005) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2005.01.017 · Cited by 113
Herson, P. S., Lee, K., Pinnock, R. D., Hughes, J. M., & Ashford, M. L. J. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.2.833 · Cited by 111
The beneficial effects of berries on cognition, motor behaviour and neuronal function in ageing
Shukitt‐Hale, B., Bielinski, D. F., Lau, F. C., Willis, L., Carey, A. N., & Joseph, J. A. (2015) · British Journal Of Nutrition · doi:10.1017/s0007114515003451 · Cited by 110
Gene Regulation by Reactive Oxygen Species
Cimino, F., Esposito, F., Ammendola, R., & Russo, T. (1997) · Current topics in cellular regulation · doi:10.1016/s0070-2137(97)80005-2 · Cited by 107
Neuroprotective effects of estradiol in mesencephalic dopaminergic neurons
Sawada, H., & Shimohama, S. (2000) · Neuroscience & Biobehavioral Reviews · doi:10.1016/s0149-7634(99)00059-7 · Cited by 103
Drug delivery strategies for Alzheimer's disease treatment
Stefano, A. D., Iannitelli, A., Laserra, S., & Sozio, P. (2011) · Expert Opinion on Drug Delivery · doi:10.1517/17425247.2011.561311 · Cited by 106
Joseph, J. A., Denisova, N. A., Bielinski, D. F., Fisher, D. R., & Shukitt‐Hale, B. (2000) · Mechanisms of Ageing and Development · doi:10.1016/s0047-6374(00)00128-7 · Cited by 104
Parihar, M. S., & Hemnani, T. (2003) · Journal of Biosciences · doi:10.1007/bf02970142 · Cited by 102
Melatonin in mitochondrial dysfunction and related disorders
Srinivasan, V., Spence, D. W., Pandi-Perumal, S. R., Brown, G. M., & Cardinali, D. P. (2011) · International Journal of Alzheimer s Disease · doi:10.4061/2011/326320 · Cited by 100
Melatonin maintains glutathione homeostasis in kainic acid‐exposed rat brain tissues
Floreani, M., Skaper, S. D., Facci, L., Lipartiti, M., & Giusti, P. (1997) · The FASEB Journal · doi:10.1096/fasebj.11.14.9409550 · Cited by 100
Reactive Oxygen Species as Mediators of Photoreceptor Apoptosisin Vitro
Carmody, R. J., McGowan, A. J., & Cotter, T. G. (1999) · Experimental Cell Research · doi:10.1006/excr.1998.4421 · Cited by 98
Protective effects of atypical antipsychotic drugs on PC12 cells after serum withdrawal
Bai, O., Wei, Z., Lu, W., Bowen, R., Keegan, D. A., & Li, X. (2002) · Journal of Neuroscience Research · doi:10.1002/jnr.10290 · Cited by 98
Antioxidant capacity of the neurohormone melatonin
Sofic, E., Rimpapa, Z., Kundurović, Z., Šapčanin, A., Tahirović, I., Rustembegovic, A., & Cao, G. (2005) · Journal of Neural Transmission · doi:10.1007/s00702-004-0270-4 · Cited by 97
Shukitt‐Hale, B., Galli, R. L., Meterko, V., Carey, A. N., Bielinski, D. F., McGhie, T. K., & Joseph, J. A. (2005) · AGE · doi:10.1007/s11357-005-4004-9 · Cited by 97
Attenuation of levodopa-induced toxicity in mesencephalic cultures by pramipexole
Carvey, P. M., Pieri, S., & Ling, Z. D. (1997) · Journal of Neural Transmission · doi:10.1007/bf01273182 · Cited by 97
Simultaneous edited MRS of GABA and glutathione
Saleh, M. G., Oeltzschner, G., Chan, K. L., Puts, N. A. J., Mikkelsen, M. E., Schär, M., Harris, A. D., & Edden, R. A. E. (2016) · NeuroImage · doi:10.1016/j.neuroimage.2016.07.056 · Cited by 96
Decreases in protective enzymes correlates with increased oxidative damage in the aging mouse brain
Mo, J. Q., Hom, D. G., & Andersen, J. K. (1995) · Mechanisms of Ageing and Development · doi:10.1016/0047-6374(95)01586-o · Cited by 96
Nanoparticle and Iron Chelators as a Potential Novel Alzheimer Therapy
Liu, G., Men, P., Perry, G. L., & Smith, M. A. (2009) · Methods in molecular biology · doi:10.1007/978-1-60327-029-8_8 · Cited by 95
Apoptosis modulators in the therapy of neurodegenerative diseases
Deigner, H., Haberkorn, U., & Kinscherf, R. (2000) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.9.4.747 · Cited by 94
Adenovirus in the brain: recent advances of gene therapy for neurodegenerative diseases
Barkats, M., Bilang‐Bleuel, A., Buc‐Caron, M., Castel-Barthe, M. N., Corti, O., Finiels, F., Horellou, P., Revah, F., Sabaté, O., & Mallet, J. J. (1998) · Progress in Neurobiology · doi:10.1016/s0301-0082(98)00028-8 · Cited by 94
Laposa, R. R., Huang, E. J., & Cleaver, J. E. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0610619104 · Cited by 94
Genetic and environmental risk factors in Parkinson’s disease
Veldman, B. A. J., Wijn, A. M., Knoers, N. V. A. M., Praamstra, P., & Horstink, M. W. I. M. (1998) · Clinical Neurology and Neurosurgery · doi:10.1016/s0303-8467(98)00009-2 · Cited by 91
The role of dopamine agonists in early Parkinson's disease
Watts, R. L. (1997) · Neurology · doi:10.1212/wnl.49.1_suppl_1.s34 · Cited by 88
Evidence for oxidative stress in Pick disease and corticobasal degeneration
Castellani, R. J., Smith, M. A., Richey, P. L., Kalaria, R. N., Gambetti, P., & Perry, G. L. (1995) · Brain Research · doi:10.1016/0006-8993(95)00535-x · Cited by 86
Antkiewicz‐Michaluk, L., Michaluk, J., Mokrosz, M. J., Romańska, I., Lorenc‐Koci, E., Ohta, S., & Vetulani, J. (2001) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2001.00391.x · Cited by 85
Metadata
- Authors
- Olanow, C. W.
- Affiliations
- University of South Florida (US)
- Corresponding author
- Olanow, C. W.
- ORCID
- Olanow, C. W.
- Venue
- Annals of Neurology
- Publisher
- Wiley
- Published
- 1992
- Volume
- 32
- Issue
- S1
- Pages
- S2-S9
- ISSN
- 0364-5134 (ISSN-L)
- 1531-8249
- OpenAlex
- W2156259977
- Cited by
- 382
- References
- 68
- Citations by year
- 2026: 2 · 2025: 1 · 2024: 1 · 2023: 1 · 2021: 5 · 2020: 3 · 2019: 3 · 2018: 5 · 2017: 6 · 2016: 7 · 2015: 2 · 2014: 6 · 2013: 5 · 2012: 13
- FWCI
- 3.32
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Annals of Neurology (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Clinical Neurology › Parkinson's Disease Mechanisms and Treatments
- Life Sciences › Neuroscience › Neurology › Neurological diseases and metabolism
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Nuclear Receptors and Signaling
- Keywords
- Parkinson's disease, oxidative stress, iron accumulation, substantia nigra, dopaminergic neurons, neuromelanin, dopamine oxidation, neuroprotection, antioxidants, neurodegeneration
- MeSH terms
- Animals, Free Radicals, Humans, Iron, Parkinson Disease, Substantia Nigra, Lipid Peroxidation
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review